| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/19/2013 | US20130245000 Bicyclic gpr119 modulators |
| 09/19/2013 | US20130244999 Substituted Heterocyclic Compounds |
| 09/19/2013 | US20130244325 Mitochondrial targeted stimulators of apoptosis |
| 09/19/2013 | US20130243754 Heterocyclic compounds and methods of use |
| 09/19/2013 | US20130243727 Triazoles as inhibitors of fatty acid synthase |
| 09/18/2013 | EP2639230A1 Prolinamide derivative as thrombin inhibitor, preparation method and application thereof |
| 09/18/2013 | EP2639226A1 Anti-infective pyrimidines and uses thereof |
| 09/18/2013 | EP2639220A1 Indole derivatives and their use as antibiotics |
| 09/18/2013 | EP2638036A1 Compound for increasing kinase active and application thereof |
| 09/18/2013 | EP2638034A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| 09/18/2013 | EP2638033A1 Compounds useful for inhibiting chk1 |
| 09/18/2013 | EP2638032A1 Tetrazolyl - tetrahydropyridine compounds for inflammation and immune - related uses |
| 09/18/2013 | EP2638031A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators |
| 09/18/2013 | EP2638030A1 Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof |
| 09/18/2013 | EP2638029A1 Triazole derivatives and their use for neurological disorders |
| 09/18/2013 | EP2638021A2 Metalloenzyme inhibitor compounds |
| 09/18/2013 | EP2638018A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors |
| 09/18/2013 | EP2638015A1 Substituted bicyclic carboxamide and urea derivatives as vanilloid receptor ligands |
| 09/18/2013 | EP2638012A1 Pyridyl ureas as mineralocorticoid receptor antagonists |
| 09/18/2013 | EP2638011A1 Novel microbiocides |
| 09/18/2013 | EP2638008A1 Lactam derivatives useful as orexin receptor antagonists |
| 09/18/2013 | EP2637669A2 Heterocyclic compounds and uses thereof |
| 09/18/2013 | EP2637659A1 Sgc stimulators |
| 09/18/2013 | CN1697655B Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 09/18/2013 | CN103313978A Pyrazole aminopyrimidine derivatives as LRRK2 modulators |
| 09/18/2013 | CN103313977A 1-(heterocyclic carbonyl) piperidines |
| 09/18/2013 | CN103313976A SGC stimulators |
| 09/18/2013 | CN103313973A N-benzyl heterocyclic carboxamides |
| 09/18/2013 | CN103313970A Novel bicyclic compound or salt thereof |
| 09/18/2013 | CN103305212A Wavelength-adjustable diarylethenyl quinoxalinyl pyridazinone organic luminescent material and preparation method thereof |
| 09/18/2013 | CN103304602A Dabigatran etexilate gluconate, and preparation method and application thereof |
| 09/18/2013 | CN103304572A 3-cyanoquinoline compound as well as pharmaceutical composition and application thereof |
| 09/18/2013 | CN103304552A Substituted pyridine compound as well as application method and usage thereof |
| 09/18/2013 | CN103304542A Rupatadine fumarate compound |
| 09/18/2013 | CN103304541A Viral polymerase inhibitors |
| 09/18/2013 | CN103304540A Phosphorescent host material and preparation method thereof, and organic electroluminescent device |
| 09/18/2013 | CN103304539A Dabigatran etexilate malate, and preparation method and application thereof |
| 09/18/2013 | CN103304538A Method for synthesizing dextromefloquine |
| 09/18/2013 | CN102603619B Compound with anticancer activity and preparation method thereof |
| 09/18/2013 | CN102532016B 5-aminoquinoline-2(1H) ketone compound and synthetic method and application thereof |
| 09/18/2013 | CN102199145B Compound for the treatment of gastrointestinal disease |
| 09/18/2013 | CN102060848B Preparation and application of aromatic amine substituted pyrimidine derivatives |
| 09/18/2013 | CN102015679B 1-substituted pyridyl-pyrazolyl amide compounds and uses thereof |
| 09/18/2013 | CN102006873B Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/18/2013 | CN101910150B 4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 09/18/2013 | CN101878199B 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 09/18/2013 | CN101652364B New indole derivative compounds and pharmaceutical compositions containing the same |
| 09/18/2013 | CN101636388B Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
| 09/18/2013 | CN101511795B 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof |
| 09/18/2013 | CN101384581B Benzoyl-piperidine derivatives as 5HT2/D3 modulators |
| 09/17/2013 | US8536340 Cross-linked cyclic amine compounds and agents for pest control |
| 09/17/2013 | US8536333 Neutral metallic dendrimer complexes |
| 09/17/2013 | US8536229 Acetylene derivatives having MGluR 5 antagonistic activity |
| 09/17/2013 | US8536205 Photochromic and electrochromic compounds and synthesis and use thereof |
| 09/17/2013 | US8536204 Amides and thioamides as pesticides |
| 09/17/2013 | US8536202 Triazole-substituted anthranilamides as pesticides |
| 09/17/2013 | US8536198 Piperidine derivatives as modulators of chemokine receptor activity |
| 09/17/2013 | US8536197 Imidazole carbonyl compound |
| 09/17/2013 | US8536186 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 09/17/2013 | US8536185 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases |
| 09/17/2013 | US8536183 3-pyridylcarbonyl-piperazinylsulfonyl derivatives |
| 09/17/2013 | US8536182 Benzylpiperazine derivatives and their medical use |
| 09/17/2013 | US8536181 Prolyl hydroxylase inhibitors |
| 09/17/2013 | US8536177 Therapeutic agents useful for treating pain |
| 09/17/2013 | US8536169 Compounds |
| 09/17/2013 | US8536166 Inhibitors of Burton's tyrosine kinase |
| 09/17/2013 | US8536164 Fused pyridine compounds as casein kinase inhibitors |
| 09/17/2013 | US8536092 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents |
| 09/17/2013 | US8535655 Biodegradable polymer—bioactive moiety conjugates |
| 09/17/2013 | CA2775616C Salts of benzimidazole compound and application thereof |
| 09/17/2013 | CA2732101C Aurora kinase modulators and methods of use |
| 09/17/2013 | CA2686382C Phenylaminopyrimidine derivatives and compositions thereof as c-kit and pdgfr kinase inhibitors |
| 09/17/2013 | CA2607280C Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists |
| 09/17/2013 | CA2570903C N-hydroxyamide derivatives and use thereof |
| 09/17/2013 | CA2566138C Piperazine derivatives and their use in controlling pests |
| 09/12/2013 | WO2013134660A1 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors |
| 09/12/2013 | WO2013134562A1 Triazolone compounds and uses thereof |
| 09/12/2013 | WO2013134371A1 Methods and compounds to be used in the treatment of neurodegenerative diseases |
| 09/12/2013 | WO2013134061A1 Phenicol antibacterials |
| 09/12/2013 | WO2013133726A1 Rodenticidal norbormide analogues |
| 09/12/2013 | WO2013132253A1 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| 09/12/2013 | WO2013131935A1 Pyridinone and pyridazinone derivatives as mch - receptor modulators |
| 09/12/2013 | WO2013131424A1 4-quinazoline amine derivative and application thereof |
| 09/12/2013 | WO2013131235A1 Two-photon fluorescent probe using naphthalene as matrix and preparation method and use thereof |
| 09/12/2013 | WO2013032960A3 Vitamin d receptor - coregulator inhibitors |
| 09/12/2013 | US20130237708 Optically Active Cyclic Alcohol Compound And Method For Preparing The Same |
| 09/12/2013 | US20130237545 Pyridazine derivatives, compositions and methods for treating cognitive impairment |
| 09/12/2013 | US20130237529 Compound that can inhibit ubc13-uev interactions, pharmaceutical compositions and therapeutic uses |
| 09/12/2013 | US20130237528 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 09/12/2013 | US20130237525 Lactam derivatives useful as orexin receptor antagonists |
| 09/12/2013 | US20130237522 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 09/12/2013 | US20130237518 Novel compounds that are erk inhibitors |
| 09/12/2013 | US20130237515 New compounds, pharmaceutical compositions and uses thereof |
| 09/12/2013 | US20130237514 Pyrrolidinone carboxamide derivatives |
| 09/12/2013 | US20130237502 Phenicol antibacterials |
| 09/11/2013 | EP2636672A1 Imidazole derivatives and preparation method and use thereof |
| 09/11/2013 | EP2636669A1 Pyrazole amide compound and use thereof |
| 09/11/2013 | EP2635566A1 Benzimidazole inhibitors of leukotriene production |
| 09/11/2013 | EP2635565A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k- delta inhibitors |
| 09/11/2013 | EP2635564A1 N-hetarylmethyl pyrazolylcarboxamides |